Sc Worx Corp. WORX
We take great care to ensure that the data presented and summarized in this overview for SCWorx Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding WORX
View allLatest Institutional Activity in WORX
Top Purchases
Top Sells
About WORX
SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion and automation; EMR management; CDM management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company operates an online event ticketing platform focused on serving regional mixed martial arts. In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.
Insider Transactions at WORX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
May 15
2024
|
Steven Ross Horowitz Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,111
-100.0%
|
-
|
|
May 15
2024
|
Alton F Irby Iii Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,001
-100.0%
|
-
|
|
May 15
2024
|
Vincent Michael Matozzo Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,056
-100.0%
|
-
|
|
Apr 11
2023
|
John C Ferrara Director |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+50.0%
|
-
|
|
Apr 11
2023
|
Steven Ross Horowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+50.0%
|
-
|
|
Apr 11
2023
|
Alton F Irby Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+50.0%
|
-
|
|
Sep 14
2021
|
Timothy Andrew Hannibal Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+50.0%
|
-
|
|
Sep 14
2021
|
Christopher John Kohler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+50.0%
|
-
|
|
Aug 19
2021
|
Steven Wallitt Director |
SELL
Open market or private sale
|
Direct |
100,000
-24.21%
|
$300,000
$3.13 P/Share
|
|
Aug 11
2021
|
John C Ferrara Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,667
+50.0%
|
-
|
|
Aug 11
2021
|
Steven Ross Horowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,667
+50.0%
|
-
|
|
Aug 09
2021
|
Marc Sanford Schessel > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-19.34%
|
$200,000
$4.2 P/Share
|
|
Aug 03
2021
|
Marc Sanford Schessel > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-30.74%
|
$100,000
$2.25 P/Share
|
|
Jul 21
2021
|
Marc Sanford Schessel > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-29.43%
|
$300,000
$2.43 P/Share
|
|
Jun 17
2021
|
Mark Shefts Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.05%
|
$5,000
$1.71 P/Share
|
|
Jun 16
2021
|
Mark Shefts Director |
SELL
Open market or private sale
|
Direct |
5,000
-48.25%
|
$5,000
$1.7 P/Share
|
|
Jun 09
2021
|
Mark Shefts Director |
SELL
Open market or private sale
|
Direct |
20,000
-50.23%
|
$40,000
$2.19 P/Share
|
Last 12 Months Summary
| Sale (or disposition) back to the issuer | 39.2K shares |
|---|